Pharmacy |
| ||
|
Glinil M Glucovance |
|
| ||
Home » Prescription Drugs 8 » Glinil M Glucovance The combination of glyburide and metformin is used to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) in people whose diabetes cannot be controlled by diet and exercise alone. Glyburide belongs to a class of drugs called sulfonylureas and metformin is in a class of drugs called biguanides. Glyburide lowers blood sugar by stimulating the pancreas the organ that makes insulin. Insulin helps control blood sugar levels. The pancreas must produce insulin for this medication to work. Metformin helps your body regulate the amount of glucose (sugar) in your blood. It decreases the amount of glucose you get from your diet and the amount made by your liver. It also helps your body use its own insulin more effectively. Glyburide and metformin are not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). Buy Glinil M Glucovance and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Glinil M Glucovance: Product Type: Prescription Drugs 8 Glinil M ( Glucovance Generic Glyburide & Metformin ) Glinil M (Glucovance Generic Glyburide & Metformin) Glucovance Generic Glyburide & Metformin 5/500mg 100 Tablets 200 Tablets 400 Tablets Glucovance Generic Glyburide & Metformin Glinil M
View more Prescription Drugs 8 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
